Italia Markets open in 8 hrs 29 mins

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
131,38+8,69 (+7,08%)
Alla chiusura: 04:00PM EDT
132,20 +0,82 (+0,62%)
Dopo ore: 06:55PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente122,69
Aperto123,89
Denaro132,02 x 1200
Lettera133,80 x 1000
Min-Max giorno123,30 - 131,77
Intervallo di 52 settimane61,28 - 159,84
Volume2.549.935
Media Volume1.344.318
Capitalizzazione11,533B
Beta (5 anni mensile)0,97
Rapporto PE (ttm)N/D
EPS (ttm)-7,11
Prossima data utili02 mag 2023 - 08 mag 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A151,00
  • GlobeNewswire

    Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on January 31, 2022 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 40 individuals hired by Sarepta in January 2023. The equity awards were approved in accordance with Nasdaq Listing

  • GlobeNewswire

    Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2022 Net Product Revenues

    - The Company expects to exceed 2022 full-year guidance for net product revenues - Preliminary net product revenues for the fourth quarter and full-year 2022 are expected to total $235.5 million and $843.3 million, respectively - Preliminary year-end 2022 cash balance of approximately $2.0 billion CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported preliminary* fourth quarter and

  • GlobeNewswire

    Sarepta Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

    CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 9, 2023 at 1:30 p.m. E.T. / 10:30 a.m. P.T. Following the presentation there will be a Q&A session starting at 1:50 p.m. E.T. / 10:50 a.m. P.T. The presentation will be webcast live under the E